Progyny, Inc.
PGNY
$22.97
$0.120.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 332.87M | 324.04M | 298.43M | 286.63M | 304.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 332.87M | 324.04M | 298.43M | 286.63M | 304.09M |
| Cost of Revenue | 253.90M | 248.24M | 235.00M | 227.38M | 235.81M |
| Gross Profit | 78.97M | 75.80M | 63.43M | 59.24M | 68.28M |
| SG&A Expenses | 54.62M | 51.63M | 47.65M | 46.79M | 47.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 308.52M | 299.87M | 282.64M | 274.17M | 283.40M |
| Operating Income | 24.36M | 24.17M | 15.79M | 12.46M | 20.69M |
| Income Before Tax | 27.08M | 26.54M | 17.66M | 17.96M | 25.07M |
| Income Tax Expenses | 9.97M | 11.48M | 7.13M | 7.54M | 8.58M |
| Earnings from Continuing Operations | 17.11M | 15.06M | 10.53M | 10.42M | 16.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.11M | 15.06M | 10.53M | 10.42M | 16.49M |
| EBIT | 24.36M | 24.17M | 15.79M | 12.46M | 20.69M |
| EBITDA | 25.56M | 25.28M | 16.66M | 13.30M | 21.44M |
| EPS Basic | 0.20 | 0.18 | 0.12 | 0.12 | 0.18 |
| Normalized Basic EPS | 0.20 | 0.19 | 0.13 | 0.12 | 0.14 |
| EPS Diluted | 0.19 | 0.17 | 0.12 | 0.11 | 0.17 |
| Normalized Diluted EPS | 0.19 | 0.19 | 0.12 | 0.12 | 0.14 |
| Average Basic Shares Outstanding | 85.77M | 85.50M | 85.81M | 90.07M | 93.87M |
| Average Diluted Shares Outstanding | 89.64M | 89.31M | 88.91M | 93.82M | 97.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |